AI Medical Device Regulation Advisory India
Advisory on CDSCO regulations for AI-based medical devices — SaMD classification and clinical evaluation
AMLEGALS advises on ai medical device regulation advisory india — regulatory mapping, sector advisory, DPDPA compliance and regulator engagement.
The issues that decide the outcome
India’s AI regulatory landscape is a composite of horizontal statutes — the Digital Personal Data Protection Act 2023 (DPDPA), the Information Technology Act 2000, the Consumer Protection Act 2019 — and sector-specific regulations issued by RBI (digital lending, KYC automation, algorithmic trading), SEBI (algo trading, robo-advisory, AI surveillance), IRDAI (AI underwriting, telematics, claims), CDSCO (AI medical devices, SaMD), DGCA (AI drones), TRAI (AI in telecom, OTT), and others. India does not have a standalone AI Act, but the NITI Aayog’s Responsible AI principles and the IndiaAI Mission provide a policy framework. AMLEGALS advises AI companies across every sector on navigating this fragmented regulatory landscape — identifying applicable obligations, interpreting ambiguous provisions, representing before regulators, and structuring operations for compliance without stifling innovation.
Key regulatory pressure points for AI companies include: consent management and purpose limitation under DPDPA; intermediary liability and content-moderation obligations under the IT Act and IT Rules; algorithmic fairness and transparency expectations of financial regulators; clinical-trial and safety requirements for AI medical devices; drone operation and BVLOS approvals; competition law scrutiny of algorithmic pricing and market dominance; export controls on dual-use AI technology; and government procurement standards for AI systems. AMLEGALS provides regulatory mapping, impact analysis, regulator engagement strategy and pre-submission advisory across all these domains.
How AMLEGALS acts
Regulatory mapping
Mapping all applicable regulations, guidelines and regulatory expectations for the AI company’s specific technology and sector of deployment.
DPDPA advisory for AI
Advising on DPDPA compliance for AI data processing — consent architecture, purpose limitation, data principal rights and cross-border transfers.
Sector-specific advisory
Providing sector-specific regulatory advisory for AI in financial services (RBI, SEBI), healthcare (CDSCO), insurance (IRDAI), telecom (TRAI), and other regulated industries.
Regulator engagement
Preparing submissions, responses to regulatory queries, and representing AI companies before regulators in inspection and inquiry proceedings.
Regulatory sandbox participation
Advising on applications and participation in AI regulatory sandboxes operated by RBI, SEBI, IRDAI and other regulators.
Policy advisory and advocacy
Advising AI industry bodies and companies on regulatory policy, providing inputs to public consultations and regulatory reform proposals.
Continue to the relevant page
Frequently asked questions
01Does India have a dedicated AI law?
India does not have a standalone AI Act. AI is governed by a composite of existing laws — the DPDPA 2023, IT Act 2000, Consumer Protection Act 2019 — and sector-specific regulations by RBI, SEBI, IRDAI, CDSCO and others. The NITI Aayog’s Responsible AI principles provide a non-binding policy framework, and the IndiaAI Mission aims to promote AI development.
02How does DPDPA 2023 apply to AI companies?
The DPDPA applies to any Data Fiduciary processing personal data of Indian data principals. AI companies that collect, store, process or make decisions based on personal data must comply with consent requirements, purpose limitation, data minimisation, storage limitation, data principal rights and cross-border transfer restrictions.
03What RBI regulations apply to AI in banking?
RBI’s digital lending guidelines, KYC directions, IT governance framework, cyber security framework and outsourcing directions apply to AI deployments in banking. AI-based credit-scoring must comply with fair-lending principles, and AI-powered customer-facing chatbots must comply with customer-protection norms.
04What are the regulatory requirements for AI medical devices?
AI-based medical devices including Software as a Medical Device (SaMD) are regulated by CDSCO under the Medical Devices Rules 2017. Classification depends on the intended use and risk level. Clinical evaluation, performance testing and quality-management documentation are required before market authorisation.
05Does an initial discussion create a lawyer-client relationship?
No. No engagement is treated as accepted until conflicts, scope and terms are confirmed in writing. An initial discussion is confidential and is used only to understand the matter and assess fit.
Request a confidential assessment
Share the key facts for a confidential preliminary assessment of your India matter.